Transcutaneous Vagus Nerve Stimulation (taVNS) for Major Depressive Disorder: An Open Label Proof-of-Concept Trial
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Despite recent advances in pharmacological treatments, Major Depressive Disorder (MDD) remains an incapacitating psychiatric condition with increasing prevalence and economic burden [1]. New therapeutical strategies such as vagus nerve stimulation (VNS) are being studied [2]. Different brain sites can be modulated by using electrical currents, which can theoretically restore balance to impaired circuits leading to clinical amelioration of symptoms. VNS involves the direct stimulation of the vagus nerve leading to further modulation of impaired brain areas related to psychiatric disorders [3,4]. Target stimulated areas include solitary tract nucleus, dorsal raphe, locus coeruleus, parabrachial area, amygdala, nucleus accumbent, hippocampus and the dorsolateral prefrontal cortex (DLPFC) [5]. Non-invasive VNS stimulation protocols have been assessed with promising results [6]. In fact, our group and others have recently proposed a hypothetically safer non-invasive approach for transcutaneously stimulating the vagus nerve in the ear, transcutaneous auricular VNS (taVNS) [7]. There are also methods for noninvasively stimulating the vagus nerve in the neck, or cervical region, called transcutaneous cervical VNS (tcVNS).We undertook this proofof-concept study to evaluate both the safety and potential clinical efficacy of this new experimental protocol with taVNS for treating patients with MDD. The present protocol had approval from institutional review board. Patients diagnosed with MDD according to the DSM-V criteria were recruited in an outpatient university hospital clinic. Symptom severity was assessed by the 17-itemHamilton Depression Rating Scale (HDRS). Exploratory analyses assessed depressive symptoms through the Beck Depression Inventory (BDI), anxiety symptoms through the Hamilton Anxiety Rating Scale (HAMA) and the Beck Anxiety Inventory (BAI), sleep quality through the Pittsburgh Sleep Quality Index (PSQI), and somatic symptoms through the Somatic Symptom Inventory (SSI) and the Somatoform Disorders Screening Instrument-7 days (SOMS-7). We also assessed cognitive functions with the Montreal Cognitive Assessment instrument (MoCA). Inclusion criteria were as follows: (1) 18to 59-year-old patients, (2) patients diagnosed with MDD following DSM-V criteria, (3) agreement to participate in the trial with written informed consent. Exclusion criteria were the following: (1) imminent need for psychiatric hospitalization, (2) any other [current or lifetime] psychiatric diagnosis, (3) neurologic or other severe diseases such as neoplastic syndromes and neurodegenerative and uncompensated chronic comorbidities, and (4) pregnancy. Clinical assessment was performed by a trained psychiatrist at baseline, at the last day of the stimulation protocol and one month after. The primary outcome was assessed by the mean difference in HDRS scores between baseline and the last day of stimulation. Participants were required to have at least four weeks without a change in psychiatric medication before the beginning of taVNS stimulation until the end of the one-month follow-up period. All patients underwent a 10-session taVNS protocol during a twoweek period. Electrical stimulationwas performed using the Ibramed Neurodyn II external neurostimulator to deliver electric current through the auricular branch of the vagus nerve at 120 Hz with a pulse wave duration of 250 μs for 30 minutes per day. The intensity was set at 12mA, which provoked a nonpainful mild paresthesia without muscle contraction for all patients. We performed the stimulation placing the electrodes bilaterally over the mastoid process area (anode to the left and cathode to the right), juxtaposed to the ear, near the tympanomastoid fissure (see Fig. 1) [8]. We used 15 cm2 auto-adhesive rubber electrodes to deliver the current. The present work was performed at the Interdisciplinary Center for Clinical Neuromodulation, Santa Casa School of Medical Sciences, São Paulo, Brazil. Figure 1. Anode positioning over the mastoid process area, juxtaposed to the ear. The cathode was positioned in the same way over the right mastoid process area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nock, M. K., & Kessler, R. C. (2006) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.115.3.616 · Cited by 680 · cited 1×
“Despite recent advances in pharmacological treatments, Major Depressive Disorder (MDD) remains an incapacitating psychiatric condition with increasing prevalence and economic burden [1].”
BackgroundHein, E., Nowak, M., Kiess, O., Biermann, T., Bayerlein, K., Kornhuber, J., & Kraus, T. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-012-0908-6 · Cited by 282
Cited by
Yap, J. Y. Y., Keatch, C., Lambert, E., Woods, W., Stoddart, P. R., & Kameneva, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00284 · Cited by 432
Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review
Redgrave, J., Day, D., Leung, H., Laud, P. J., Ali, A., Lindert, R., & Majid, A. (2018) · Brain Stimulation · doi:10.1016/j.brs.2018.08.010 · Cited by 320
Tu, Y., Fang, J., Cao, J., Wang, Z., Park, J., Jorgenson, K., Lang, C., Liu, J., Zhang, G., Zhao, Y., et al. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.01.006 · Cited by 104
Richter, F., García, A. M., Rodriguez Arriagada, N., Yoris, A., Birba, A., Huepe, D., Zimmer, H., Ibáñez, A., & Sedeño, L. (2021) · Human Brain Mapping · doi:10.1002/hbm.25288 · Cited by 46
“Appropriate integration of bodily signals appears to be of central importance for adaptive cognitive and emotional processing (Critchley and Garfinkel, 2017, Critchley & Garfinkel, 2018; Farb et al., 2015; Tsakiris & Critchley, 2016).”
BackgroundSackeim, H. A., Dibué, M., Bunker, M. T., & Rush, A. J. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s286977 · Cited by 15
Metadata
- Authors
- Trevizol, A. P., Shiozawa, P., Taiar, I., Soares, A., Gomes, J. S., Barros, M. D., Liquidato, B. M., & Cordeiro, Q.
- Venue
- Brain Stimulation
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 9
- Issue
- 3
- Pages
- 453-454
- ISSN
- 1876-4754 (ISSN-L)
- 1935-861X
- OpenAlex
- W2254545602
- Cited by
- 65
- References
- 2
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.